Ken Takanashi
CPA
Finance
sastuma pharmaceuticals
Japan
Biography
Since 2004, Ken has served as an Executive Board Member at Shin Nippon Biomedical Laboratories, Ltd. (JPX:2395), a contract research organization that provides pre-clinical and clinical services for drug development to pharmaceutical and biotech companies and conducts translational research business. Ken has experience working for more than 30 companies in the US, Japan, Singapore, China, Malaysia, India, Hong Kong, Cambodia and Bhutan, has been a board member for over 20 years, and has experience establishing various biotech companies and contract research organizations. Ken currently serves as a director of WAVE Life Sciences, Ltd. (NASDAQ:WVE) and played a key role in establishing WAVE as a spinout from SNBL. Ken received a Bachelor’s degree from the University of Tokyo and a MBA from the University of Warwick. He also has a qualification as a Certified Public Accountant (Delaware State, US).
Research Interest
Buisness Management
